$IBOGF-Average VolumeUniversal Ibogaine Inc. is seen to be doing well in the OTC market with its ticker symbol $IBOGF. The average volume in the last 30 days is recorded to be above $8K.
IBOGF trade ideas
$IBO Stock StatementUniversal Ibogaine Inc. is an expanding Canadian-holding company with an average volume of $145K+ in the last 3 months. The average volume of the company in the last 10 days is $112K with $190.74M share outstanding. The stock price when the market opened was $0.05
The Co-Founder’s administration over 3K Ibogaine DetoxThe Co-Founder’s administration over 3K Ibogaine Detox
Universal Ibogaine Co-Founder Dr Alberto Sola has administered over 3700 ibogaine Detox treatments, more than any other doctor in the world.
Ibogaine has been shown to provide rapid and relatively painless opioid detox and to reset the brain to a pre-addicted state.
Ibogaine as an addiction curer
Ibogaine has been shown to provide rapid and relatively painless opioid detox and to reset the brain to a pre-addicted state.Ibogaine is a plant medicine that can cure someone of opioid addiction in one dose. This company is developing a worldwide treatment center network.
$IBO Stock AnalysisUniversal Ibogaine Inc. is an expanding Canadian-holding company with an average volume of $145K in the last 3 months. During the last 10 days the average volume remained $112K with $190M share outstanding.
$IBO Upper and Lower Price in the Last 52 WeeksUniversal Ibogaine Inc. holds a significant position over the TSX-V market with its greater difference between the lower and higher ranges of trading, which is $0.0400-$0.2500 in the last 52 weeks.
$IBOGF driving investors fanatical with profit$IBO over the years have maintained a solid and supple market cap, currently the company’s market capitalization is valued over $7.57M and is mounting effectively and the shares are actively being traded on OTC at $0.0376 per unit.
$IBOGF market capitalization at the apex, investors overwhelmed $IBO over the years have maintained a solid and supple market cap, currently the company’s market capitalization is valued over $7.57M and is mounting effectively
Universal Ibogaine Market SummaryUniversal Ibogaine Inc. is a Canadian Life science Company trading at OTC with ticker symbol $IBOGF currently sits at $0.0376 with volume around 10K+.
$IBOGF Stock EvaluationUniversal Ibogaine Inc. is an expanding Canadian-holding company with an average volume of $7K in the last 3 months. The average volume of the company in the last 10 days is $5.02K with $190.74M share outstanding. The stock price when the market opened was $0.0397.
Universal Ibogaine Market SummaryUniversal Ibogaine Inc. holds a significant position over the TSX-V market with its greater difference between the lower and higher ranges of trading, which is $0.04-$0.25 in the last 52 weeks.
Universal Ibogaine Stock SummaryUniversal Ibogaine Inc. is an expanding Canadian-holding company with an average volume of $139K+ in the last 3 months. The average volume of the company in the last 10 days is $81.88K with $190.74M share outstanding. The stock price when the market opened was $0.045.
UI CEO’s rapturous to work with Blue Digital Media"We are happy to have access to Blue Digital's distribution channels, as their range across borders will broaden awareness of our business to new audiences," said Nick Karos, UI's Chief Executive Officer. Because addiction knows no bounds, the remedy we seek must be global in scope." As Blue Digital Media professional radar.
Dr. Sola's administration over 3700 Ibogaine Detox
Universal Ibogaine Co-Founder Dr Alberto Sola has administered over 3700 ibogaine detox treatments, more than any other doctor in the world.
$IBO Stock Analysis GraphUniversal Ibogaine Inc. is an expanding Canadian-holding company with an average volume of $172K+ in the last 3 months. The average volume of the company in the last 10 days is $97K with $190.16M share outstanding. The stock price when the market opened was $0.05.
$IBO shares trading unobstructed on the TSX-V$IBO is gliding swiftly on the TSX-V Index, the shares are trading currently at $0.05 which might get doubled in the upcoming days or week maximum.
$IBO CO-Founder with wide ranging work-experienceDr. Sola, a co-founder of Universal Ibogaine and a member of its Board of Directors, has effectively administered over 3,700 ibogaine treatments, more than any other doctor in the world, at an independent clinic in Cancun, Mexico, where he is a partner.
$IBO’S CEO comments on the H.C Wainwright"H.C. Wainwright is a leader in the field and may be a significant strategic partner in our ongoing corporate finance roadmap," said Nick Karos, CEO of Universal Ibogaine. Another crucial step in raising awareness of our brand and service is the chance to share our story with this audience.
CEO highlights on the sheer extent of the research to reality ev"The significance of this occasion cannot be emphasized," said CEO Nick Karos. This is the first gathering of academic researchers, real-world technicians, and government policymakers of its sort. This event will raise awareness of ibogaine's great potential at the highest levels."
Universal Ibogaine Inc. CEO’s ecstatic to work with Blue Digital
"We are happy to have access to Blue Digital's distribution channels, as their range across borders will broaden awareness of our business to new audiences," said Nick Karos, UI's Chief Executive Officer. Because addiction knows no bounds, the remedy we seek must be global in scope." As Blue Digital Media professional radar.
$HEM announcement related to the Stock Options GrantHemostemix Inc. announced that in accordance with its stock option plan, it has granted on February 28, 2022, subject to regulatory approval, a total of 1,494,269 stock options to purchase common shares of Hemostemix to directors, officers, employees and consultants of Hemostemix
$IBO announced a vital addition of clinical trials directorJulie Dumouchel has been named Director of Clinical Trials at UI, which is a significant strategic move. Julie Dumouchel has 25 years of experience in the pharmaceutical sector, where she has worked in a variety of clinical research jobs and has a thorough grasp of the drug development process.
Universal Ibogaine Inc. Market GraphUniversal Ibogaine Inc. holds a significant position over the OTC market with its greater difference between the lower and higher ranges of trading, which is $0.0258-$0.1143 in the last 52 weeks.
